Skip to main navigation Skip to search Skip to main content

An evidence-based analysis of the management of N0 neck in patients with cancer of the parotid gland

  • Jose Guilherme Vartanian*
  • , Joao Gonçalves Filho
  • , Luiz Paulo Kowalski
  • , Jatin P. Shah
  • , Carlos Suárez
  • , Alessandra Rinaldo
  • , Remco De Bree
  • , Juan P. Rodrigo
  • , Marc Hamoir
  • , Robert P. Takes
  • , Antti A. Mäkitie
  • , Peter Zbären
  • , Simon Andreasen
  • , Vincent Vander Poorten
  • , Alvaro Sanabria
  • , Henrik Hellquist
  • , K. Thomas Robbins
  • , Carsten C. Bödeker
  • , Carl Silver
  • , Alfio Ferlito
  • *Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

1 Downloads (Pure)

Abstract

Introduction: Management of clinically negative neck (cN0) in patients with parotid gland cancer is controversial. Treatment options can include observation, elective neck dissection or elective radiotherapy. Areas covered: We addressed the treatment options for cN0 patients with parotid gland cancer. A literature review was undertaken to determine the optimal management of this group of patients. Expert opinion: Patients with parotid carcinoma and clinically negative neck have various options for their management. The analysis of tumor stage, histology and grade is essential to better define patients at risk for occult lymph node metastasis. These patients can be managed by surgery, radiotherapy or their combination, depending on the presence of risk factors, the moment at which such risk factors are detected, patient-related clinical conditions, medical provider expertise and institutional facilities.

Original languageEnglish
Pages (from-to)899-908
Number of pages10
JournalExpert Review of Anticancer Therapy
Volume19
Issue number10
DOIs
Publication statusPublished - 3 Oct 2019

Keywords

  • elective neck treatment
  • neck dissection
  • parotid gland
  • radiotherapy
  • Salivary gland

Fingerprint

Dive into the research topics of 'An evidence-based analysis of the management of N0 neck in patients with cancer of the parotid gland'. Together they form a unique fingerprint.

Cite this